ep discuss follow earlier publish note street ep
guid higher discuss key takeaway antm
earn call publish follow-up note discuss ep bridg
first light ep guidanc rais least
least rais ep view reflect slightli
lower tax modestli better trend overal base result
trend better commerci vs government segment second given net posit
put take discuss next year increas ep view
reflect growth hypothet adjust baselin ep
ad back hif headwind current ep guidanc greater
new estim also emb addl group live
growth individu addl virginia medicaid expans live
ep outlook discuss figur modestli rais
ep estim model return hif tax follow
hif holiday possibl return hif could success lobbi
away assum stay intact
beyond conserv estim also assum modest benefit
initi transit antm pbm servic need away current vendor esrx
ep estim reflect full annual contribut least
mln expect pharmaci cost save fall antm bottom line
bln total expect save pbm transit complet
mln benefit translat increment ep given high visibility/low
execut risk relat captur pharmaci cost save surpris
alreadi factor antm current share price price-to-earnings
ep believ investor begin price pbm opportun
greater visibl ep bridg
rais pt price-to-earnings ep view
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight price target
base price-to-earnings ep
compani set stage acceler ep growth
bn pbm save unlock follow
conclus express script vendor contract
upsid case base higher price-to-earnings
ep increas earn visibl
new pbm contract higher expect
downsid case base lower price-to-earnings
ep reflect risk associ
increas cost trend aggress commerci
price lower expect medicar growth
lower visibl earn new pbm
 compani insur milself-fund miltot medic mil individu aca-compli local membership medicar medicaid membership choic livesoper billoc group /- /- /- /- bpsconsolid medic /- /- /- /- bpssg expensesg ratio incl /- /- /- /- bpsoper gaingreat bilgreat bilgreat bilgreat bilinvest milinterest milamort miladj epsgreat epsgreat flowgreat bilgreat bilgreat bilgreat bilshar milshar bilnotestax reform contributestax reform contributestax reform contributestax reform add live mn add live mn inmedicaidmedicaid barclay
inc quarterli membership analysi statist commerci medicar medicar govern medic changen commerci medicar medicar govern medic fund type insur medic chang insur medic barclay
inc oper revenu revenueactualactualactualprojectedprojectedprojectedprojectedprojectedcommerci specialti oper changecommerci specialti oper gain/losscommerci specialti oper amort one-tim invest total compani margincommerci specialti nm nm nm nm nm nm nm total oper changecommerci specialti oper barclay
inc quarterli incom statement mil ep ep compon oper invest oper invest medic loss expens ex one-tim oper addback expens exclud oper incom total oper rate minor interest check fulli dilut ep start dilut share barclay
inc annual incom statement mil ep ep ep compon oper invest oper invest medic loss expens ex one-tim oper addback expens exclud oper incom total oper rate minor interest check fulli dilut ep start dilut share growth expens ex one-tim oper incom barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
